DANVERS, Mass.--(BUSINESS WIRE)--Abiomed, Inc. (NASDAQ: ABMD) today announced the release of data on its Impella 2.5 presented at the American College of Cardiology’s (ACC) 56th Annual Scientific Sessions. ACC is the premier cardiovascular medical meeting, bringing together approximately 30,000 cardiologists to share developments in cardiovascular medicine.
